Phosphorylation at Ser-15 and Ser-392 in mutant p53 molecules from human tumors is altered compared to wild-type p53.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (55)
p53 Mutations in Human Cancers
1991 • 8,133 citations
Participation of p53 protein in the cellular response to DNA damage.
1991 • 3,818 citations
Definition of a consensus binding site for p53
1992 • 2,000 citations
p53 function and dysfunction
1992 • 1,918 citations
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
1990 • 1,796 citations
[11] Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates
1991 • 1,463 citations
Identification of p53 as a Sequence-Specific DNA-Binding Protein
1991 • 1,109 citations
p53 mutations in colorectal cancer.
1990 • 1,030 citations
Regulation of the specific DNA binding function of p53
1992 • 914 citations
UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells.
1984 • 874 citations
Presence of a Potent Transcription Activating Sequence in the p53 Protein
1990 • 811 citations
Structural aspects of the p53 protein in relation to gene evolution.
1990 • 618 citations
Wild-type p53 activates transcription in vitro
1992 • 609 citations
Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.
1990 • 502 citations
Human DNA-Activated Protein Kinase Phosphorylates Serines 15 and 37 in the Amino-Terminal Transactivation Domain of Human p53
1992 • 473 citations
Multisite and hierarchal protein phosphorylation
1991 • 419 citations
Human cells contain a DNA-activated protein kinase that phosphorylates simian virus 40 T antigen, mouse p53, and the human Ku autoantigen.
1990 • 415 citations
Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes.
1990 • 409 citations
Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2.
1990 • 353 citations
p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines.
1991 • 349 citations
p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer.
1992 • 278 citations
The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II.
1990 • 277 citations
Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression.
1991 • 251 citations
Maintenance of p53 alterations throughout breast cancer progression.
1991 • 244 citations
UV Irradiation Stimulates Levels of p53 Cellular Tumor Antigen in Nontransformed Mouse Cells
1984 • 225 citations
Association of a murine 53,000-dalton phosphoprotein with simian virus 40 large-T antigen in transformed cells
1980 • 222 citations
p53: the ultimate tumor suppressor gene?
1992 • 209 citations
A C-terminal alpha-helix plus basic region motif is the major structural determinant of p53 tetramerization.
1992 • 193 citations
The nuclear serine/threonine protein kinase DNA-PK.
1992 • 192 citations
The p53 tumor suppressor protein, a modulator of cell proliferation.
1992 • 171 citations
Mutant p53 proteins bind DNA abnormally in vitro.
1991 • 166 citations
Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells
1992 • 161 citations
p53 interacts with p34cdc2 in mammalian cells: implications for cell cycle control and oncogenesis.
1990 • 156 citations
Human Cells Contain a DNA-Activated Protein Kinase that Phosphorylates Simian Virus 40 T Antigen, Mouse p53, and the Human Ku Autoantigen
1990 • 144 citations
Nuclear protein phosphorylation and growth control
1992 • 135 citations
Phosphorylation of the p53 tumour-suppressor protein at three N-terminal sites by a novel casein kinase I-like enzyme.
1992 • 121 citations
A DNA binding domain is contained in the C-terminus ofwild typep53 protein
1991 • 113 citations
Analysis of p53 mutants for transcriptional activity.
1991 • 106 citations
Mutation of the casein kinase II phosphorylation site abolishes the anti-proliferative activity of p53
1992 • 105 citations
Human wild-type p53 adopts a unique conformational and phosphorylation state in vivo during growth arrest of glioblastoma cells.
1992 • 99 citations
The involvement of oncogenes and tumor suppressor genes in the control of apoptosis
1992 • 99 citations
Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.
1992 • 96 citations
Association of casein kinase II with immunopurified p53.
1991 • 86 citations
Phosphorylation sites in the amino-terminal region of mouse p53.
1992 • 74 citations
Synthetic phosphopeptides are substrates for casein kinase II
1990 • 72 citations
Cell cycle regulation and the p53 tumor suppressor protein.
1992 • 52 citations
Characterization of Synthetic Peptide Substrates for p34cdc2 Protein Kinase
1991 • 41 citations
Purification and partial amino acid sequence analysis of the cellular tumour antigen, p53, from mouse SV40-transformed cells.
1983 • 38 citations
Overlap of the p53-responsive element and cAMP-responsive element in the enhancer of human T-cell leukemia virus type I.
1992 • 32 citations
Analysis of p53 Mutants for Transcriptional Activity
1991 • 31 citations
p53 mosaicism with an exon 8 germline mutation in the founder of a cancer-prone pedigree.
1992 • 30 citations
Eukaryotic Cell-Cycle Control
1992 • 20 citations
Permanent expression of p53 in FR 3T3 rat cells but cell cycle-dependent association with large-T antigen in simian virus 40 transformants.
1985 • 17 citations
Cell Cycle Effects of Microinjected Antisense Oligodeoxynucleotides to p34cdc2 Kinasea
1992 • 11 citations
Partial transformation of human tumor cell lines showing defective interaction between unusual p53 gene product and SV40 large-T antigen.
1990 • 10 citations